Associations of 25-hydroxyvitamin D status and vitamin D supplementation use with mortality due to 18 frequent cancer types in the UK Biobank cohort

Although the associations of serum 25-hydroxyvitamin D (25(OH)D) levels and vitamin D supplementation with total cancer mortality are well-known, evidence regarding the association of 25(OH)D and cancer site-specific mortality is predominantly limited to common cancer types, and most studies on vita...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Sha, Sha (VerfasserIn) , Chen, Li-Ju (VerfasserIn) , Brenner, Hermann (VerfasserIn) , Schöttker, Ben (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: September 2023
In: European journal of cancer
Year: 2023, Jahrgang: 191, Pages: 1-13
ISSN:1879-0852
DOI:10.1016/j.ejca.2023.113241
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.ejca.2023.113241
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S095980492300343X
Volltext
Verfasserangaben:Sha Sha, Li-Ju Chen, Hermann Brenner, Ben Schöttker
Beschreibung
Zusammenfassung:Although the associations of serum 25-hydroxyvitamin D (25(OH)D) levels and vitamin D supplementation with total cancer mortality are well-known, evidence regarding the association of 25(OH)D and cancer site-specific mortality is predominantly limited to common cancer types, and most studies on vitamin D supplementation use have limitations on sample size and the adjustment of important confounding factors.
Beschreibung:Online veröffentlicht am 17. Juli 2023, Artikelversion vom 5. August 2023
Gesehen am 08.11.2023
Beschreibung:Online Resource
ISSN:1879-0852
DOI:10.1016/j.ejca.2023.113241